Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes. Kishimori T, Kato T, Iwasaki Y, Shimada T, et al. Diabetes Obes Metab 2026 Jan 5. doi: 10.1111/dom.70433.

Read + Share

Amedeo Smart

Independent Medical Education

Kishimori T, Kato T, Iwasaki Y, Shimada T, et al. Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes. Diabetes Obes Metab 2026 Jan 5. doi: 10.1111/dom.70433.
PMID: 41492180